Skip to content

The clinical outcomes of MPA and Duphaston and Utrogestan in Primed-progesterone ovarian stimulation protocol for patients with polycystic ovarian syndrome undergoing IVF cycle

The clinical outcomes of MPA and Duphaston and Utrogestan in Primed-progesterone ovarian stimulation protocol for patients with polycystic ovarian syndrome undergoing IVF cycle

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17012998
Enrollment
Unknown
Registered
2017-10-16
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: The medical records of 1140 Chinese women undergoing IVF- ET cycles and reaching the oocyte pick-up stage at Reproductive Medical Center, Shanghai Ninth People's Hospital, Shanghai Jiaotong University, between October 2012 and December 2013 were reviewed. All patients should meet the PCOS definition specified in the 1990 National Institute of Health-National institute of Child Health and Human Development conference or in 2003 Rotterdam conference by the European Society for Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM); Aged 20-38 years, FSH less than 10IU/L, BMI<25.

Exclusion criteria

Exclusion criteria: male factor, ovarian failure, severe endometrosis, acute genital tract infection and other systemtic diseases.

Design outcomes

Primary

MeasureTime frame
the number of oocyte retrieval;maturation rate;implantation rate;incidence of premature LH;

Secondary

MeasureTime frame
clinical pregnancy rate;fertilization rate;

Contacts

Public ContactYanping Kuang

Shanghai Nineth People's Hospital

kuangyanp@126.com+86 021-53078080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026